- Previous Close
391.00 - Open
383.00 - Bid 373.00 x --
- Ask 376.00 x --
- Day's Range
366.00 - 384.00 - 52 Week Range
366.00 - 645.00 - Volume
272,600 - Avg. Volume
240,270 - Market Cap (intraday)
14.121B - Beta (5Y Monthly) 1.00
- PE Ratio (TTM)
-- - EPS (TTM)
-19.77 - Earnings Date May 12, 2025 - May 16, 2025
- Forward Dividend & Yield 15.50 (3.96%)
- Ex-Dividend Date Dec 29, 2025
- 1y Target Est
430.00
Medical Data Vision Co., Ltd. develops, produces, maintains, and sells medical information integration systems in Japan. The company offers data network services; data utilization services; MDV act, an analysis application that enables hospitals to preview hospital management indicators; and Karteco, a personal health record enables users to independently manage their health and medical information. It also provides research, and consulting services for various medical data; business consulting services for medical institutions; and operation and related service of various medical data. In addition, it engages in the planning, design, development, and operation of portal websites. The company serves hospitals, clinics, and companies. Medical Data Vision Co., Ltd. was incorporated in 2003 and is headquartered in Tokyo, Japan.
www.mdv.co.jp315
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: 3902.T
View MorePerformance Overview: 3902.T
Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is Nikkei 225 (^N225) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 3902.T
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 3902.T
View MoreValuation Measures
Market Cap
14.12B
Enterprise Value
12.77B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.53
Price/Book (mrq)
4.77
Enterprise Value/Revenue
2.28
Enterprise Value/EBITDA
102.33
Financial Highlights
Profitability and Income Statement
Profit Margin
-13.39%
Return on Assets (ttm)
0.03%
Return on Equity (ttm)
-21.50%
Revenue (ttm)
5.91B
Net Income Avi to Common (ttm)
-791M
Diluted EPS (ttm)
-19.77
Balance Sheet and Cash Flow
Total Cash (mrq)
1.35B
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-712.12M